Monte Rosa Therapeutics, Inc.
← Back to GLUE Overview

Monte Rosa Therapeutics, Inc. (GLUE)

Revenue & Top-Line Growth

Latest Revenue

$4.2M

Financial Fundamentals

GLUEQuarterly Data • 5Y View

Historical Revenue Data

Quarterly Revenue Breakdown

DateRevenue ($B)QoQ %YoY %TTM ($B)TTM %
2026-03-310.00B+51.4%-95.0%0.04B-73.1%
2025-12-310.00B-78.2%-95.4%0.12B+63.5%
2025-09-300.01B-45.0%+38.5%0.18B+1112.3%
2025-06-300.02B-72.7%+394.0%0.18B+2990.6%
2025-03-310.08B+40.0%+7882.0%0.16B+14889.4%
2024-12-310.06B+558.1%0.08B
2024-09-300.01B+96.3%0.01B
2024-06-300.00B+341.3%0.01B
2024-03-310.00B0.00B
2023-12-310.00B0.00B
2023-09-300.00B0.00B
2023-06-300.00B0.00B
2023-03-310.00B0.00B
2022-12-310.00B0.00B
2022-09-300.00B0.00B
2022-06-300.00B0.00B
2022-03-310.00B0.00B
2021-12-310.00B0.00B
2021-09-300.00B0.00B
2021-06-300.00B0.00B
2021-03-310.00B0.00B
2020-12-310.00B0.00B
2020-09-300.00B0.00B
2020-06-300.00B0.00B
2020-03-310.00B0.00B

Annual Revenue

YearTotal Revenue ($B)Growth %
20250.12B+63.5%
20240.08B
20230.00B
20220.00B
20210.00B
20200.00B
20190.00B